CollPlant Biotechnologies (CLGN) Research & Development (2017 - 2026)
CollPlant Biotechnologies' Research & Development came in at $1.68 million for the quarter ended Mar 30, 2026, down 20.3% from $2.11 million a year earlier and down 15.3% from the prior quarter.
CollPlant Biotechnologies (CLGN) Research & Development (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 30, 2026, CollPlant Biotechnologies reported Research & Development of $7.76 million, down 24.0% year-over-year; for the year ended Dec 31, 2025, it was $8.19 million, down 22.1% from the prior year.
- Research & Development carries a five-year compound annual growth rate of 15.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Research & Development was $10.52 million in the year ended Dec 31, 2024 (+0.3%), $10.48 million in the year ended Dec 31, 2023 (+2.2%), $10.26 million in the year ended Dec 31, 2022 (+34.4%) and $7.63 million in the year ended Dec 31, 2021 (+87.7%).
- The figure for the quarter ended Mar 30, 2026 represents the lowest quarterly Research & Development since the quarter ended Mar 31, 2021.
- Year-over-year, Research & Development has declined for six consecutive quarters, with an average decline of 14.3% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in the quarter ended Sep 30, 2021 (growth of 107.2%), and the weakest in the quarter ended Sep 30, 2025 (a decline of 27.2%).
- Business Quant data shows CLGN's Research & Development at $1.98 million (quarter ended Dec 31, 2025), $2.09 million (quarter ended Sep 30, 2025) and $2.01 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | 1.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 30, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.57 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Sep 30, 2022 | 2.78 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 2.24 Mn |
| Dec 31, 2021 | 2.19 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.90 Mn |
CollPlant Biotechnologies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();